Percutaneous techniques for cervical pain of discal origin.

Cervical discogenic pain is an important cause of suffering and disability in the adult population. Pain management in cervical disc herniation relies initially on conservative care (rest, physiotherapy, and oral medications). Once conservative treatment has failed, different percutaneous minimally invasive radiological procedures can be applied to relief pain. This article offers a systematic review on the percutaneous minimally invasive techniques that can be advocated for the treatment of cervical pain of discal origin. Periradicular steroid injection under image guidance (computed tomography or magnetic resonance imaging) is the first technique to be considered. The steroid injection aims at reducing the periradicular inflammation and thus relieves the radicular pain. The steroid injections present satisfying short-term results, but pain can recur in the long term. Whenever the steroid injections fail to relieve pain from a contained cervical disc herniation, the more invasive percutaneous disc decompression techniques should be proposed. Percutaneous radiofrequency nucleoplasty is the most often applied technique on the cervical level with a low risk of thermal damage. When the indications and instructions are respected, radiofrequency nucleoplasty presents accepted safety and efficacy levels.

18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?

The understanding of radiotracer's physiological biodistribution as well as the potential source of false-positive results is crucial for an accurate diagnostic interpretation of (18)F-fluorocholine PET/CT examination in patients with prostate cancer. We illustrate the results of whole-body (18)F-fluorocholine PET/CT in a 79-year-old man with biochemical suspicion of prostate adenocarcinoma relapse. PET/CT study showed a focally increased (18)F-fluorocholine uptake, characterizing an incidentally found adrenocortical adenoma. Finally, we draw oncologists' attention to the possible false-positive results of (18)F-fluorocholine PET related to benign and unsuspected adrenocortical lesions in patients with a history of prostate malignancy.

Aportes de la espectroscopía por resonancia magnética en las lesiones cerebrales / The contribution of the Magnetic Resonance Spectroscopy in the brain lesions Introduction

Introducción: La Espectroscopía por Resonancia Magnética (ERM) es una técnica no invasiva que permite un análisis del metabolismo de las lesiones o del tejido normal, aumentando la especificidad del método. De esta manera, a la información morfológica aportada por las imágenes de resonancia magnética (RM) se le suma la información bioquímica que brinda la ERM. Si bien el "gold standard" para establecer el diagnóstico definitivo de una lesión cerebral sigue siendo la biopsia, la ERM es un método no invasivo y libre de complicaciones que posibilita determinar el tipo de lesión y evitar biopsias innecesarias en procesos no tumorales. El objetivo del presente trabajo es comprobar si la ERM monovóxel protón de hidrógeno (H+) de tiempo de eco (TE) largo es capaz de discriminar la naturaleza tumoral o no de las lesiones cerebrales y clasificarlas en grados de malignidad. Material y método: Se trata de un estudio prospectivo en el que se incluyó a pacientes de ambos sexos y de distintas edades a los que se les realizó un estudio estándar de RM completado con ERM monovoxel. Resultados: Se analizaron 47 lesiones y se caracterizaron adecuadamente 43 (92,9%), con una sensibilidad (S) del 96,8% (IC 89-100), una especificidad (E) del 89,6% (IC 76-100), un valor predictivo positivo (VPP) del 91,1% (IC 80-100) y un valor predictivo negativo (VPN) del 96,3% (IC 87-100). Muchas son las variables que influyen en la adquisición de un espectro factible de ser analizado, pudiendo surgir de éstas diferencias inter-observador. Sin embargo, se obtuvieron resultados similares a los de otras publicaciones. Conclusión: La ERM sumada a la RM demostró ser un método confiable para determinar la naturaleza tumoral o no de una lesión cerebral, con valores estadísticos aceptables.

The Magnetic Resonance Spectroscopy (MRS) is a non-invasive technique which allows study of the metabolism of lesions or of normal tissue, increasing the method's specificity. In this way, the biochemical information provided by MRS is added to the morphologic information provided by the Magnetic Resonance Imaging (MRI). Even though the gold standards to determine the definite diagnosis of a brain lesion is still the biopsy, the MRS is a non-invasive method, free of complications which would help determine the type of lesion and avoid unnecessarybiopsies in non-tumor processes. The objective of this work is to determine if the monovoxel MRS hydrogen proton (H+) long Eco Time (TE) is capable to differentiating or not the nature of the tumor from the brain lesions and classify them into levels of malignity. Material and Method: This is a retrospective study in which female and male patients of any ages were selected. A standard study of MRI was performed in them and it was completed with monovoxel ERM. Results: 47 lesions were analyzed and 43 (92.9%) were adequately characterized, with a sensibility (S) of 96.8% (IC 89-100), specificity (E) of 89.6% (IC 76-100), positive predictive value (PPV) of 91.1% (IC 80-100) and a negative predictive value (NPV) of 96.3% (IC 87-100). There are many variables that can influence the acquisition of a spectrum capable of being analyzed and from them, inter-observer differences can emerge. However, our results were similar to those in other publications. Conclusion: The MRS together with the MRI proved to be a reliable method to determine whether a brain lesion is a tumor or not, with acceptable statistic values.